LINNAEUS THERAPEUTICS, INC.

Profile

Company Names

LINNAEUS THERAPEUTICS, INC.

Addresses

30 WASHINGTON AVENUE, SUITE F, HADDONFIELD, NJ 08033

Phone Numbers

(856) 433-1500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$23,844,064.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2026-02-17 
$4,992,000.00 
$10,000,000.00 
$5,008,000.00 
Equity 
6
2025-08-19 
$1,275,000.00 
$10,000,000.00 
$8,725,000.00 
Debt 
5
2024-08-12 
$5,824,155.00 
$6,860,000.00 
$1,035,845.00 
Equity 
4
2023-01-24 
$3,088,234.00 
$3,088,234.00 
$0.00 
Equity 
3
2021-08-09 
$4,344,675.00 
$4,344,675.00 
$0.00 
Equity 
2
2019-01-23 
$2,160,000.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2018-08-27 
$2,160,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRIS 
 
ARENDT 
DIRECTOR
JAMES 
 
DEMETRIADES 
DIRECTOR
NICHOLAS 
 
IATROPOULOS 
DIRECTOR
NICHOLAS 
T. 
IATROPOULOS 
DIRECTOR
JACK 
 
LEPPING 
DIRECTOR
JOHN 
 
LEPPING 
DIRECTOR
PATRICK 
 
MOONEY 
EXECUTIVE OFFICER, DIRECTOR
PATRICK 
T. 
MOONEY 
EXECUTIVE OFFICER, DIRECTOR
CHRISTOPHER 
 
NATALE 
EXECUTIVE OFFICER
MICHAEL 
 
POISEL 
DIRECTOR
MICHAEL 
D. 
POISEL 
DIRECTOR
TODD 
T. 
THOMSON 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-08-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-08-12 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#